Altman Z Score Analysis of Akums Drugs and Pharmaceuticals Ltd. - Deep Dive
Latest FY Altman Z Score
Period Ending - Mar-25
Excellent Altman Z Score
6.32
Period Ending - Mar-24
Not Good Altman Z Score
1.69
Growth
272.89 %
Latest Altman Z Score
Period Ending - 07-Dec-25
Excellent Altman Z Score
5.95
Key Inputs in Deriving Altman Z Score
| (Net Working Capital / Total Assets ) * 1.2 ( 1380.86 Cr / 4113.44 Cr ) * 1.2 | 0.403 |
| (Retained Earning / Total Assets ) * 1.4 ( 1829.43 Cr / 4113.44 Cr ) * 1.4 | 0.623 |
| (EBIT / Total Assets ) * 3.3 ( 379.85 Cr / 4113.44 Cr ) * 3.3 | 0.305 |
| (Total Revenue / Total Assets ) ( 4118.16 Cr / 4113.44 Cr ) | 1.00 |
| (Market Cap / Total Liabilities ) *.6 ( 6430.29 Cr / 1066.43 Cr ) *.6 | 3.62 |
| Altman Z Score | 5.95 |
Other Altman Z Score Related Info of AKUMS that may interest you.
Akums Drugs and Pharmaceuticals Ltd. Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| AKUMS | 420.00 | 420.30 | 0.071 % | Drugs & Pharma |
Defination of Altman Z Score
Altman Z Score is a widely used metric by analysts and investors to analyze companies' financial position. It indicates that the companies' risks were increasing, and they may have been heading towards bankruptcy. It does not only indicate whether companies are moving towards bankruptcy, but it also indicates how financially stable and healthy they are. more ..
Altman Z Score Related Ratios
| PiotroskiFScore | DebtToEquityRatio |
Tsr Stability Index
| Excellent Stability | Screener |
FY - Historical Altman Z Score of Akums Drugs and Pharmaceuticals Ltd.
| Period | Mar-25 | Mar-24 | Mar-23 | Mar-22 |
|---|---|---|---|---|
| Altman Z Score | 6.32 | 1.69 | 1.83 | 1.50 |
| Change | 272.89 % | -7.62 % | 21.98 % | |
| Price | 473.20 | 0 | 0 | 0 |
| Price Change |
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPoint
Beta&Vols
Tech Charts